These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 9558165)
1. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis. Nossent JC J Rheumatol; 1998 Apr; 25(4):654-9. PubMed ID: 9558165 [TBL] [Abstract][Full Text] [Related]
2. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895 [TBL] [Abstract][Full Text] [Related]
3. Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement. Brunner HI; Feldman BM; Urowitz MB; Gladman DD J Rheumatol; 2003 Feb; 30(2):292-7. PubMed ID: 12563683 [TBL] [Abstract][Full Text] [Related]
4. The effect of menopause on disease activity in systemic lupus erythematosus. Urowitz MB; Ibañez D; Jerome D; Gladman DD J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295 [TBL] [Abstract][Full Text] [Related]
5. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Fortin P; Ginzler E; Gordon C; Hanly JG; Isenberg DA; Petri M; Nived O; Snaith M; Sturfelt G J Rheumatol; 2000 Feb; 27(2):373-6. PubMed ID: 10685799 [TBL] [Abstract][Full Text] [Related]
6. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Mok CC; Ho LY; Cheung MY; Yu KL; To CH Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189 [TBL] [Abstract][Full Text] [Related]
7. A comparison of prospective and retrospective evaluations of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Bernatsky S; Clarke A; Abrahamowicz M; Neville C; Karp I; Pineau CA J Rheumatol; 2005 May; 32(5):820-3. PubMed ID: 15868615 [TBL] [Abstract][Full Text] [Related]
8. [Significance of damage index in predicting systemic lupus erythematosus outcome]. Tarasova IA; Ivanova MM; Zhorniak AP; Nasonova VA Ter Arkh; 2003; 75(1):59-62. PubMed ID: 12652960 [TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage. Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146 [TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627 [TBL] [Abstract][Full Text] [Related]
12. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. Becker-Merok A; Nossent HC J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708 [TBL] [Abstract][Full Text] [Related]
13. Accrual of organ damage over time in patients with systemic lupus erythematosus. Gladman DD; Urowitz MB; Rahman P; Ibañez D; Tam LS J Rheumatol; 2003 Sep; 30(9):1955-9. PubMed ID: 12966597 [TBL] [Abstract][Full Text] [Related]
14. Socioeconomic status and health in women with systemic lupus erythematosus. Lotstein DS; Ward MM; Bush TM; Lambert RE; van Vollenhoven R; Neuwelt CM J Rheumatol; 1998 Sep; 25(9):1720-9. PubMed ID: 9733452 [TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD; Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840 [TBL] [Abstract][Full Text] [Related]
16. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159 [TBL] [Abstract][Full Text] [Related]
17. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices. Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044 [TBL] [Abstract][Full Text] [Related]
18. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Mikdashi J; Handwerger B Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927 [TBL] [Abstract][Full Text] [Related]
19. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809 [TBL] [Abstract][Full Text] [Related]
20. Fibromyalgia is a major contributor to quality of life in lupus. Gladman DD; Urowitz MB; Gough J; MacKinnon A J Rheumatol; 1997 Nov; 24(11):2145-8. PubMed ID: 9375874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]